Panax Ginseng

evidence score
adaptogen
Korean ginsengAsian ginsengred ginseng+2 more

Panax ginseng is one of the most studied herbal adaptogens, used in Traditional Chinese Medicine for millennia. Active constituents are ginsenosides (>40 identified), which have steroid-like structures and modulate a wide range of pathways. Clinical evidence supports cognitive performance (working memory, attention, mental fatigue), immune modulation, blood glucose control, erectile function, and modest testosterone support. Red ginseng (steamed/dried root) has higher ginsenoside bioavailability and stronger evidence than white ginseng. Distinct from American ginseng (Panax quinquefolius) and Siberian ginseng (Eleutherococcus).

Evidence

No score yet

Safety

Unknown safety profile

Clinical Status

No formal phase listed

Research Sync

Not synced yet

Dosing

Typical
400 mg
200 mgRange1000 mg
Frequency1-2x/day

Set height & weight in Settings to see your dose.

Pharmacology

Half-lifeGinsenosides: ~4-16 hours depending on compound
OnsetCognitive effects acute to 1 week; adaptogenic/hormonal effects 4-12 weeks
DurationOngoing with regular use; tolerance may develop over months
Routes
oral

Evidence Score

0 studies indexed
Scoring Factors
Volume(40%)
Quality(30%)
Sample Size(10%)
Consistency(10%)
Replication(5%)
Recency(5%)
Evidence Levels
AScore ≥75 with at least 1 meta-analysis and 3+ RCTs
BScore ≥50 with at least 1 RCT or meta-analysis
CScore ≥25 — observational or animal evidence only
DScore <25 — very limited or preclinical data

Plain-English Snapshot

Panax Ginseng is currently categorized as a adaptogen compound.

Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.

Safety scoring is incomplete. Start conservatively and monitor carefully.

Core mechanism

Ginsenosides activate glucocorticoid receptors, modulate NO production, inhibit neuroinflammation, enhance ACh signaling, support HPG axis via LH stimulation

Practical Context

Strongest current signals

No indexed study summaries yet.

Compound Profile